Biofilm-producing antibiotic-resistant bacteria in Indian patients: a comprehensive review

Susmita Datta1, Soma Nag1, Dijendra Nath Roy2

  • 1Department of Chemical Engineering, National Institute of Technology, Agartala, Tripura, India.

PubMed

Insights

Microbial biofilms pose a significant healthcare threat due to increasing antibiotic resistance. Common bacteria like Escherichia, Streptococcus, and Staphylococcus form these resistant biofilms in Indian patients, complicating infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Microbial biofilms are a growing threat in healthcare, contributing to persistent and difficult-to-treat infections.
  • Biofilms protect bacteria from antibiotics and host immune responses, particularly on indwelling medical devices.
  • Antibiotic resistance in biofilm-forming bacteria is a major global health concern.

Purpose of the Study:

  • To review the prevalence of biofilm-forming bacteria and their antibiotic resistance in Indian patients.
  • To identify common bacterial species associated with biofilm formation and resistance.
  • To highlight the impact of biofilms on various infection types.

Main Methods:

  • Literature review of approximately 30 clinical research reports from PubMed.
  • Analysis of studies focusing on biofilm formation and antibiotic resistance in Indian patient populations.
  • Identification of prevalent bacterial species and associated infection types.

Main Results:

  • A high prevalence of biofilm formation was observed in bacteria such as Escherichia, Streptococcus, Staphylococcus, and Pseudomonas species.
  • These bacteria demonstrated significant resistance to common antibiotics prescribed by clinicians.
  • Biofilm-associated infections were common in urinary tract, respiratory tract, dental, skin, and implant-associated infections among Indian patients.

Conclusions:

  • Biofilm-forming bacteria, particularly Escherichia, Streptococcus, Staphylococcus, and Pseudomonas, are prevalent in Indian patients.
  • These bacteria exhibit multi-drug resistance, exacerbating healthcare-associated infections.
  • The increasing prevalence of biofilm-associated infections necessitates targeted therapeutic strategies.

Related Concept Videos

Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...